Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-03-28
1995-05-09
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514643, 514912, 514914, A61K 3147, A61K 3114
Patent
active
054140110
ABSTRACT:
Stable, clear, antimicrobially effective, ophthalmic formulations are disclosed which provide an antimicrobially effective preservative. The formulations include an ophthalmologically effective amount of a drug, which is a --COOH group-containing non-steroidal anti-inflammatory drug (NSAID) alone or in combination with an antibiotic drug, and a preservative system formed of a quaternary ammonium preservative and a nonionic polyoxyethylated octylphenol surfactant, all in an aqueous vehicle. The preservative system can be used with other formulations which require the preservative to be ophthamologically acceptable and antimicrobially effective. These formulations are useful for treating diseases and/or conditions that are either caused by, associated with or accompanied by inflammatory processes, including, among others, glaucoma, cystoid macular edema, uveitis, diabetic retinopathy and conjunctivitis, or any trauma caused by eye surgery or eye injury. When the formulation is further comprised of an ophthalmologically acceptable antibiotic, the antibiotic is preferably tobramycin which has been found not to interfere with the rate of diffusion of the NSAID. The combination of the NSAID and antibiotic is particularly effective in simultaneously preventing and/or eliminating infection while preventing and/or eliminating inflammation.
REFERENCES:
patent: 4087538 (1978-05-01), Portnoff
patent: 4087539 (1978-05-01), Muchowski et al.
patent: 4089969 (1978-05-01), Muchowski et al.
patent: 4097579 (1978-06-01), Muchowski et al.
patent: 4230724 (1980-10-01), Cooper et al.
patent: 4232038 (1980-11-01), Kluge et al.
patent: 4336151 (1982-06-01), Like et al.
patent: 4336152 (1982-06-01), Like et al.
patent: 4349563 (1982-09-01), Gilbert et al.
patent: 4454157 (1984-06-01), Waterbury
patent: 4474751 (1984-10-01), Haslan et al.
patent: 4474811 (1984-10-01), Masuda et al.
patent: 4500538 (1985-02-01), Waltersdorf
patent: 4559343 (1985-12-01), Han et al.
patent: 4607038 (1986-08-01), Ogata et al.
Chem Abst 103:115887g (1985). Mahoney et al.
The Condensed Chemical Dictionary, Seventh Ed., Reinhold Publishing Co., N.Y., p. 985.
McCutcheon's "Emulsifiers and detergents" North American Ed., 1983 p. 154.
Schmolka, Irving R. J. Soc. Cosmet. Chem. 24, 577-592 (Aug. 9, 1973).
"Influence of (Ethoxy).sub.5 Octyl Phenol on the Antibacterial Properties of Preservatives", M. T. Nadir, et al., Journal of Pharmacy and Pharmacology, vol. 29, Supplement, Dec. 1977, p. 67P.
"Ocufen (flurbioprofen sodium) 0.03% Liquifilm steril ophthalmic solution," Allergan, product description sheet, one page.
Remington's Pharmaceutical Sciences, 15th Ed., pp. 1489-1504, (1975).
Fu Cherng-Chyi R.
Lidgate Deborah M.
Fay Zohreh
Freyberg Derek P.
Syntex (U.S.A.) Inc.
LandOfFree
Preservative system for ophthalmic formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preservative system for ophthalmic formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preservative system for ophthalmic formulations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1705576